Your shopping cart is currently empty

AO-022 is a potent conformational inhibitor of TALDO1. It reduces the protein expression of vimentin and snail, exhibiting antiproliferative and antitumor activities. AO-022 holds potential for use in breast cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | AO-022 is a potent conformational inhibitor of TALDO1. It reduces the protein expression of vimentin and snail, exhibiting antiproliferative and antitumor activities. AO-022 holds potential for use in breast cancer research. |
| In vitro | AO-022 inhibits cell viability in MDA-MB-231 cells in a dose-dependent manner at concentrations of 5, 10, 20, 40, and 80 µM over 24 hours. Additionally, AO-022 reduces the protein expression of vimentin and snail in a dose-dependent fashion at concentrations of 0, 2.5, 5, 10, and 20 µM after 24 hours. |
| In vivo | AO-022, administered intraperitoneally at a dosage of 50 mg/kg every other day over a fourteen-day period, demonstrated antitumor activity in mice. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.